Suburban Diagnostics introduces Abbott ID NOW test for faster COVID-19 testing of patients in emergency cases

first_img Read Article The missing informal workers in India’s vaccine story Menopause to become the next game-changer in global femtech solutions industry by 2025 Indraprastha Apollo Hospitals releases first “Comprehensive Textbook of COVID-19” Suburban Diagnostics introduces Abbott ID NOW test for faster COVID-19 testing of patients in emergency cases Share Abbott ID NOW test reportedly needs 30 minutes to generate a report after sample collection, whereas obtaining a COVID-19 test report generally takes between 24-36 hours of time, after the regular RT-PCR testSuburban Diagnostics introduces the Abbott ID NOW test – a rapid molecular test, using a rear technology that will accelerate the reporting process, resulting in patients getting the test results faster. The test is ICMR approved and hence the reports will be valid in case of emergency treatment or hospitalisation or even for domestic travel, as per the company release.Obtaining a COVID-19 test report generally takes between 24-36 hours of time, after the regular RT-PCR test. Suburban Diagnostics’ new Abbott ID NOW test reportedly only needs 30 minutes to generate a report after sample collection. It is a faster alternative to the RT-PCR test in times of emergency, when waiting longer is not a viable option for the patient.“We have introduced this test for patients who are in an emergency and need COVID-19 test reports faster. The test will be available only at selected Suburban Diagnostics centres,” says Sushant Kinra, COO, Suburban Diagnostics. “It is our endeavour to be at the forefront in this war against the virus. We are hopeful that this facility will be instrumental in saving more lives, as it will help people in quickening the process of treatment during emergency,” he added. Adoption of AI/ML can disrupt healthcare services By EH News Bureau on April 27, 2021 center_img Related Posts Phoenix Business Consulting invests in telehealth platform Healpha COVID-19 Updates Lab Diagnostics News MaxiVision Eye Hospitals launches “Mucormycosis Early Detection Centre” Comments (0) WHO tri-regional policy dialogue seeks solutions to challenges facing international mobility of health professionals Add Commentlast_img

Leave a Reply

Your email address will not be published. Required fields are marked *